150 related articles for article (PubMed ID: 11935319)
1. Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus.
Mackay DJ; Coupe AM; Shield JP; Storr JN; Temple IK; Robinson DO
Hum Genet; 2002 Feb; 110(2):139-44. PubMed ID: 11935319
[TBL] [Abstract][Full Text] [Related]
2. A novel imprinted gene, HYMAI, is located within an imprinted domain on human chromosome 6 containing ZAC.
Arima T; Drewell RA; Oshimura M; Wake N; Surani MA
Genomics; 2000 Aug; 67(3):248-55. PubMed ID: 10936046
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.
Valleley EM; Cordery SF; Bonthron DT
Hum Mol Genet; 2007 Apr; 16(8):972-81. PubMed ID: 17341487
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the role of common genetic variation in the transient neonatal diabetes mellitus (TNDM) region in type 2 diabetes: a comparative genomic and tagging single nucleotide polymorphism approach.
Gloyn AL; Mackay DJ; Weedon MN; McCarthy MI; Walker M; Hitman G; Knight BA; Owen KR; Hattersley AT; Frayling TM
Diabetes; 2006 Aug; 55(8):2272-6. PubMed ID: 16873690
[TBL] [Abstract][Full Text] [Related]
5. The human HYMAI/PLAGL1 differentially methylated region acts as an imprint control region in mice.
Arima T; Yamasaki K; John RM; Kato K; Sakumi K; Nakabeppu Y; Wake N; Kono T
Genomics; 2006 Nov; 88(5):650-8. PubMed ID: 16928428
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus.
Varrault A; Bilanges B; Mackay DJ; Basyuk E; Ahr B; Fernandez C; Robinson DO; Bockaert J; Journot L
J Biol Chem; 2001 Jun; 276(22):18653-6. PubMed ID: 11297535
[TBL] [Abstract][Full Text] [Related]
7. Construction of 700 human/mouse A9 monochromosomal hybrids and analysis of imprinted genes on human chromosome 6.
Inoue J; Mitsuya K; Maegawa S; Kugoh H; Kadota M; Okamura D; Shinohara T; Nishihara S; Takehara S; Yamauchi K; Schulz TC; Oshimura M
J Hum Genet; 2001; 46(3):137-45. PubMed ID: 11310581
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities.
Bilanges B; Varrault A; Mazumdar A; Pantaloni C; Hoffmann A; Bockaert J; Spengler D; Journot L
Oncogene; 2001 Mar; 20(10):1246-53. PubMed ID: 11313869
[TBL] [Abstract][Full Text] [Related]
9. The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes.
Kamiya M; Judson H; Okazaki Y; Kusakabe M; Muramatsu M; Takada S; Takagi N; Arima T; Wake N; Kamimura K; Satomura K; Hermann R; Bonthron DT; Hayashizaki Y
Hum Mol Genet; 2000 Feb; 9(3):453-60. PubMed ID: 10655556
[TBL] [Abstract][Full Text] [Related]
10. Transient neonatal diabetes mellitus type 1.
Mackay DJ; Temple IK
Am J Med Genet C Semin Med Genet; 2010 Aug; 154C(3):335-42. PubMed ID: 20803656
[TBL] [Abstract][Full Text] [Related]
11. A conserved imprinting control region at the HYMAI/ZAC domain is implicated in transient neonatal diabetes mellitus.
Arima T; Drewell RA; Arney KL; Inoue J; Makita Y; Hata A; Oshimura M; Wake N; Surani MA
Hum Mol Genet; 2001 Jul; 10(14):1475-83. PubMed ID: 11448939
[TBL] [Abstract][Full Text] [Related]
12. The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas.
Pagotto U; Arzberger T; Theodoropoulou M; Grübler Y; Pantaloni C; Saeger W; Losa M; Journot L; Stalla GK; Spengler D
Cancer Res; 2000 Dec; 60(24):6794-9. PubMed ID: 11156367
[TBL] [Abstract][Full Text] [Related]
13. The mouse Zac1 locus: basis for imprinting and comparison with human ZAC.
Smith RJ; Arnaud P; Konfortova G; Dean WL; Beechey CV; Kelsey G
Gene; 2002 Jun; 292(1-2):101-12. PubMed ID: 12119104
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas.
Jarmalaite S; Laurinaviciene A; Tverkuviene J; Kalinauskaite N; Petroska D; Böhling T; Husgafvel-Pursiainen K
Cancer Genet; 2011 Jul; 204(7):398-404. PubMed ID: 21872827
[TBL] [Abstract][Full Text] [Related]
15. Transient neonatal diabetes, a disorder of imprinting.
Temple IK; Shield JP
J Med Genet; 2002 Dec; 39(12):872-5. PubMed ID: 12471198
[TBL] [Abstract][Full Text] [Related]
16. Establishment of the primary imprint of the HYMAI/PLAGL1 imprint control region during oogenesis.
Arima T; Wake N
Cytogenet Genome Res; 2006; 113(1-4):247-52. PubMed ID: 16575187
[TBL] [Abstract][Full Text] [Related]
17. Bisulphite sequencing of the transient neonatal diabetes mellitus DMR facilitates a novel diagnostic test but reveals no methylation anomalies in patients of unknown aetiology.
Mackay DJ; Temple IK; Shield JP; Robinson DO
Hum Genet; 2005 Mar; 116(4):255-61. PubMed ID: 15635480
[TBL] [Abstract][Full Text] [Related]
18. Changes in expression of imprinted genes following treatment of human cancer cell lines with non-mutagenic or mutagenic carcinogens.
Shibui T; Higo Y; Tsutsui TW; Uchida M; Oshimura M; Barrett JC; Tsutsui T
Int J Oncol; 2008 Aug; 33(2):351-60. PubMed ID: 18636156
[TBL] [Abstract][Full Text] [Related]
19. Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines.
Piras G; El Kharroubi A; Kozlov S; Escalante-Alcalde D; Hernandez L; Copeland NG; Gilbert DJ; Jenkins NA; Stewart CL
Mol Cell Biol; 2000 May; 20(9):3308-15. PubMed ID: 10757814
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
